Revvity, ES-730-CF, cAMPZen Frozen Human Chemotactic Peptide C3a Cell Line, CHO-K1 Cells

Overview
Chemotactic Peptide C3a cAMPzen cells are validated frozen cells designed for high-throughput screening to identify drug candidates targeting the human recombinant Chemotactice Peptide C3a expressed in CHO-K1 host cells. The cAMPzen technology enables researchers to easily detect changes in cAMP levels as a direct indicator of receptor activation, making it valuable tool for drug drug discovery. Each vial contains 2.5 million frozen cells validated for cAMP testing, providing a consistent and ready-to-use supply that streamlines workflows and accelerates drug discovery. The frozen format ensures reliable performance while maintaining cell viability. Please note that these cells are authorized for single-use only, and transfer, re-use, or propagation is not permitted under the product terms and conditions. Application-cAMP Drug Discovery & Development
Brand-cAMPZen
G-Alpha Natural Receptor-G i /G o
Host Cell Line-CHO-K1
Host Species-Human
One Unit Contains-1 M cells/vial
Product Group-Cell Line
Receptor-Anaphylatoxin
Second Messenger Release-cAMP GTP exchange
Shipping Conditions-Shipped in Dry Ice
Target Class-GPCR
Therapeutic Area-Immune
Unit Size-2.5 million cells
Validation-cAMP Downstream Phosphorylation